Aura Biosciences, Inc. AURA Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$33.69M-31.8% | -$25.56M+2.2% | -$26.13M+3.3% | -$27.02M+1.7% | -$27.48M-6.4% | ||
| $274K+0.7% | $272K-9.3% | $300K0.0% | $300K+3.1% | $291K0.0% | ||
| $3.82M+16.5% | $3.28M-11.0% | $3.69M-3.8% | $3.83M+9.1% | $3.51M+19.6% | ||
| $1.02M+338% | -$430K— | —— | -$720K-142% | -$298K-196% | ||
| -$2.75M— | $0-100% | $3.35M-1.2% | $3.39M+237% | -$2.48M— | ||
| $46K— | —— | —— | —— | -$518K-205% | ||
| -$386K-2.4% | -$377K-5.3% | -$358K-7.8% | -$332K-2.2% | -$325K-3.2% | ||
| -$29.89M-46.0% | -$20.47M-1.6% | -$20.14M+3.0% | -$20.77M+11.1% | -$23.36M+2.5% | ||
| $102K-42.0% | $176K+291% | $45K+15.4% | $39K-79.1% | $187K-37.5% | ||
| $54.9M+84.1% | $29.82M— | —— | $19.98M-33.0% | $29.81M+0.4% | ||
| $56K— | —— | —— | $46.52M— | $0— | ||
| $300K-89.2% | $2.77M-36.6% | $4.36M-93.8% | $69.93M+72,743% | $96K-82.3% | ||
| -$27K+83.1% | -$160K-1,043% | -$14K— | $0+100% | -$21K— | ||
| $25.31M+109% | $12.12M— | —— | $69.13M+955% | $6.55M— | ||
| $274K+0.7% | $272K-9.3% | $300K0.0% | $300K+3.1% | $291K0.0% | ||
| —— | —— | —— | —— | —— | ||
| -$386K-2.4% | -$377K-5.3% | -$358K-7.8% | -$332K-2.2% | -$325K-3.2% | ||
| -$1.73M+35.6% | -$2.68M— | —— | —— | -$3M-807% | ||
| $412K+2.5% | $402K+2.6% | $392K+2.3% | $383K+2.4% | $374K+2.5% | ||
| $0— | —— | —— | —— | $27K+2,260% | ||
| —— | —— | —— | —— | —— | ||
| $121K— | —— | $68K— | —— | $96K— | ||
| $123K— | —— | —— | —— | $0— | ||
| $20K-78.0% | $91K— | $0— | $0— | $0— | ||
| -$27K+83.1% | -$160K-1,043% | -$14K— | $0+100% | -$21K— | ||
| -$386K-2.4% | -$377K-5.3% | -$358K-7.8% | -$332K-2.2% | -$325K-3.2% | ||
| —— | $3.54M0.0% | $3.54M0.0% | $3.54M0.0% | $3.54M— | ||
| -$30M-45.3% | -$20.65M-2.3% | -$20.19M+3.0% | -$20.81M+11.6% | -$23.54M+2.9% | ||
| -$30M-45.3% | -$20.65M-2.3% | -$20.19M+3.0% | -$20.81M+11.6% | -$23.54M+2.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Aura Biosciences, Inc. generate?
- Aura Biosciences, Inc. (AURA) generated -$91.3M in operating cash flow over the trailing twelve months.
- What is Aura Biosciences, Inc.'s free cash flow?
- After $362.0K of capital expenditures, Aura Biosciences, Inc.'s free cash flow was -$91.6M over the trailing twelve months, down 14.5% year over year.
- Where does Aura Biosciences, Inc.'s cash flow data come from?
- Every line is extracted from Aura Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.